blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1105409

EP1105409 - PROTECTION OF ENDOGENOUS THERAPEUTIC PEPTIDES FROM PEPTIDASE ACTIVITY THROUGH CONJUGATION TO BLOOD COMPONENTS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  05.01.2007
Database last updated on 26.06.2024
Most recent event   Tooltip05.10.2007Change - lapse in a contracting state
State(s) deleted from list of lapses: IT
published on 07.11.2007  [2007/45]
Applicant(s)For all designated states
ConjuChem Biotechnologies Inc.
Suite 3950, Third Floor 225 President Kennedy Avenue
Montreal, QC H2X 3Y8 / CA
[2006/38]
Former [2006/09]For all designated states
ConjuChem, Inc.
3rd Floor, Suite 3950, 225 President Kennedy Avenue West
Montréal, Québec H2X 3Y8 / CA
Former [2001/24]For all designated states
Conjuchem, Inc.
3rd floor, Suite 3950, 225 President Kennedy Avenue West
Montréal, Québec H2X 3Y8 / CA
Inventor(s)01 / BRIDON, Dominique, P.
243 chemin Cote Ste-Catherine
Outremont, Quebec H2V 2B2 / CA
02 / EZRIN, Alan, M.
110 Quintas Lane
Moraga, CA 94556 / US
03 / MILNER, Peter, G.
14690 Manuella Road
Los Altos Hills, CA 94022 / US
04 / HOLMES, Darren, L.
3450 Drummond Street
Montreal, Quebec H3G 1T3 / CA
05 / THIBAUDEAU, Karen
4700 Bonavista Street, 407
Montreal, Quebec H3W 2L5 / CA
 [2001/24]
Representative(s)Larfeldt, Helene, et al
Bergensträhle & Lindvall AB
P.O. Box 17704
118 93 Stockholm / SE
[N/P]
Former [2001/24]Larfeldt, Helene, et al
Bergensträhle & Lindvall AB P.O. Box 17704
118 93 Stockholm / SE
Application number, filing date00936023.117.05.2000
[2001/24]
WO2000US13576
Priority number, dateUS19990134406P17.05.1999         Original published format: US 134406 P
US19990153406P10.09.1999         Original published format: US 153406 P
US19990159783P15.10.1999         Original published format: US 159783 P
[2001/24]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO0069900
Date:23.11.2000
Language:EN
[2000/47]
Type: A2 Application without search report 
No.:EP1105409
Date:13.06.2001
Language:EN
The application published by WIPO in one of the EPO official languages on 23.11.2000 takes the place of the publication of the European patent application.
[2001/24]
Type: B1 Patent specification 
No.:EP1105409
Date:01.03.2006
Language:EN
[2006/09]
Search report(s)International search report - published on:EP15.02.2001
ClassificationIPC:C07K1/107, C07K14/135, C07K14/16, C07K14/46, C07K14/575, C07K14/605, C07K14/645, C07K14/655, C12N9/68
[2001/24]
CPC:
C07K14/645 (EP); A61K47/62 (EP); A61P1/18 (EP);
A61P25/00 (EP); A61P25/28 (EP); A61P43/00 (EP);
A61P5/00 (EP); A61P5/48 (EP); C07K14/00 (EP);
C07K14/005 (EP); C07K14/465 (EP); C07K14/575 (EP);
C07K14/57545 (EP); C07K14/605 (EP); C07K14/62 (EP);
C07K14/76 (EP); A61K38/00 (EP); C07K2319/31 (EP);
C12N2740/16122 (EP) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2001/24]
Extension statesAL18.07.2000
LT18.07.2000
LV18.07.2000
MK18.07.2000
RO18.07.2000
SI18.07.2000
TitleGerman:SCHUTZ ENDOGENER, THERAPEUTISCH AKTIVER PEPTIDE VOR PEPTIDASEAKTIVITÄT DURCH KONJUGATION AN BLUTBESTANDTEILE[2001/24]
English:PROTECTION OF ENDOGENOUS THERAPEUTIC PEPTIDES FROM PEPTIDASE ACTIVITY THROUGH CONJUGATION TO BLOOD COMPONENTS[2001/24]
French:PROTECTION DE PEPTIDES THERAPEUTIQUES ENDOGENES CONTRE L'ACTIVITE PEPTIDASE PAR CONJUGAISON DE COMPOSANTS SANGUINS[2001/24]
Entry into regional phase18.07.2000National basic fee paid 
18.07.2000Designation fee(s) paid 
18.07.2000Examination fee paid 
Examination procedure18.07.2000Examination requested  [2001/24]
18.07.2000Request for accelerated examination filed
15.12.2000Request for preliminary examination filed
International Preliminary Examining Authority: EP
20.08.2001Despatch of a communication from the examining division (Time limit: M06)
20.08.2001Decision about request for accelerated examination - accepted: Yes
11.02.2002Reply to a communication from the examining division
21.05.2002Despatch of a communication from the examining division (Time limit: M04)
30.08.2002Reply to a communication from the examining division
16.09.2002Despatch of a communication from the examining division (Time limit: M04)
04.01.2003Reply to a communication from the examining division
25.02.2003Despatch of a communication from the examining division (Time limit: M04)
23.06.2003Reply to a communication from the examining division
11.07.2003Despatch of a communication from the examining division (Time limit: M06)
14.01.2004Reply to a communication from the examining division
07.04.2004Despatch of a communication from the examining division (Time limit: M06)
08.10.2004Reply to a communication from the examining division
09.11.2004Despatch of a communication from the examining division (Time limit: M04)
09.03.2005Reply to a communication from the examining division
30.03.2005Despatch of a communication from the examining division (Time limit: M04)
16.06.2005Reply to a communication from the examining division
25.07.2005Communication of intention to grant the patent
16.11.2005Fee for grant paid
16.11.2005Fee for publishing/printing paid
Divisional application(s)EP05105384.1  / EP1591453
EP05105387.4  / EP1598365
EP05108328.5  / EP1623994
EP08158878.2  / EP2100901
EP10185601.1
Opposition(s)04.12.2006No opposition filed within time limit [2007/06]
Fees paidRenewal fee
28.05.2002Renewal fee patent year 03
26.05.2003Renewal fee patent year 04
26.05.2004Renewal fee patent year 05
30.05.2005Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  Tooltipdeleted
[2007/45]
Former [2007/35]IT01.03.2006
Cited inInternational search[X]EP0602290  (POULETTY PHILIPPE [US], et al) [X] 1-10,12,13,16,21 * column 2, line 1 - line 22 * * column 8, line 25 - line 33; claim - *;
 [X]WO9510302  (REDCELL INC [US]) [X] 1-10,12,13,16,21 * page 18, line 10 - page 19, line 1 *;
 [A]US5580853  (SYTKOWSKI ARTHUR J [US]) [A] 1-10,12,13,16,21 * column 3, line 42 - column 4, line 38 * * column 5, line 21 - line 4 * * column 7, line 38 - line 43 *;
 [A]US5654276  (BARRETT RONALD W [US], et al) [A] 1-5 * column 3, line 28 - line 38 * * column 17, line 48 - column 18, line 8; claim - *;
 [PX]WO9924462  (CONJUCHEM INC [CA], et al) [PX] 1-26 * example -; claim - *;
 [PA]WO9924075  (CONJUCHEM INC [CA], et al) [PA] 1-26* example -; claim - *;
 [PX]WO9948536  (CONJUCHEM INC [CA], et al) [PX] 1-26 * example -; claim - *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.